The use of bioaccumulation, biomarkers and histopathology diseases in Procambarus clarkii to establish bioavailability of Cd and Zn after a mining spill.
Individuals of the crayfish Procambarus clarkii (males and females) were exposed simultaneously to cadmium and zinc during 21 days. Exposure concentrations were those determined at the Guadiamar river after the Aznalcóllar mining spill (SW, Spain): 10 and 30 microg L(-1) of cadmium and 1000 and 3000 microg L(-1) of zinc. Three biomarkers (MT: metallothioneins like proteins, VTG: vitellogenin/vitellin like proteins and histopathology) together with heavy metal bioaccumulation were determined in soft tissues of male and female P. clarkii. At the concentrations tested, increasing cadmium exposure resulted in increasing cadmium bioaccumulation and increasing subletal effects (induction of MT, VTG and histopathological damage in tissues). Nevertheless, although increasing zinc exposure showed increasing VTG induction and histopathological damages, not a positive relationship was determined with MT induction. Concerning to responses determined in male and female crayfishes only differences were found between sexes at the highest cadmium exposure concentration related to bioaccumulation in hepatopancreas tissues. Biomarkers responses to heavy metal contamination in this crayfish, even VTG induction not before tested in heavy metal contamination assessment in crustaceans resulted potential tools for the monitoring of heavy metal environmental contamination.
Martín-Díaz
M L
ML
Facultad de Ciencias del Mar y Ambientales, Campus Río San Pedro s/n, 11510, Puerto Real, Cádiz, Spain. laura.martin@uca.es
Tuberty
S R
SR
McKenney
C L
CL
Blasco
J
J
Sarasquete
C
C
Delvalls
T A
TA
D000818:Animals; D003400:Astacoidea / Q000187:drug effects* / Q000378:metabolism*; D001682:Biological Availability; D015415:Biomarkers / Q000032:analysis; D002104:Cadmium / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity*; D004784:Environmental Monitoring; D005260:Female; D005880:Gills / Q000166:cytology / Q000187:drug effects / Q000473:pathology; D006458:Hemolymph / Q000737:chemistry; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000473:pathology; D008297:Male; D008668:Metallothionein / Q000378:metabolism; D008906:Mining; D009132:Muscles / Q000187:drug effects; D010053:Ovary / Q000166:cytology / Q000473:pathology; D010179:Pancreas / Q000166:cytology / Q000187:drug effects / Q000473:pathology; D014819:Vitellogenins / Q000378:metabolism; D014867:Water / Q000737:chemistry; D015032:Zinc / Q000493:pharmacokinetics / Q000633:toxicity*
D015415:Biomarkers; D014819:Vitellogenins; D002104:Cadmium; D014867:Water; D008668:Metallothionein; D015032:Zinc